Moore Capital Management’s Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share IBER.WS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-150,000
| Closed | -$2.67K | – | 610 |
|
|
2022
Q4 | $2.67K | Hold |
150,000
| – | – | ﹤0.01% | 495 |
|
|
2022
Q3 | $11K | Hold |
150,000
| – | – | ﹤0.01% | 548 |
|
|
2022
Q2 | $12K | Hold |
150,000
| – | – | ﹤0.01% | 606 |
|
|
2022
Q1 | $30K | Hold |
150,000
| – | – | ﹤0.01% | 660 |
|
|
2021
Q4 | $81K | Hold |
150,000
| – | – | ﹤0.01% | 628 |
|
|
2021
Q3 | $90K | Hold |
150,000
| – | – | ﹤0.01% | 682 |
|
|
2021
Q2 | $114K | Buy |
+150,000
| New | +$114K | ﹤0.01% | 706 |
|